Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple-to-use, rapid, cost effective, portable system.
Need our help with your lateral flow assay growth strategy? https://t.co/Z4zDmKnw35 https://t.co/UjkKdqwhpU
26 May 2017
© Abingdon Health 2017